APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s

Alzheimer’s disease (AD) has a critical unmet medical need. The consensus around the amyloid cascade hypothesis has been guiding pre-clinical and clinical research to focus mainly on targeting beta-amyloid for treating AD. Nevertheless, the vast majority of the clinical trials have repeatedly failed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Anna, Kantor, Boris, Chiba-Falek, Ornit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865856/
https://www.ncbi.nlm.nih.gov/pubmed/33513969
http://dx.doi.org/10.3390/ijms22031244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865856/
https://www.ncbi.nlm.nih.gov/pubmed/33513969
http://dx.doi.org/10.3390/ijms22031244

Ejemplares similares